CClinicalTrials.gg
Active, not recruitingNCT06342531eDASA+APP FIUpdated Apr 6, 2025

More Effective Violence Risk Management - eDASA+APP FI

An interventional study of eDASA+APP FI in Violence, sponsored by University of Turku. Active, not recruiting at 1 site in Finland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-06.

Sponsored by University of Turku · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The main goal of this study is to evaluate if the Finnish version of eDASA+APP (electronic Dynamic Appraisal of Situational Aggression + Aggression Prevention Protocol), a clinical decision support system (CDSS), has an impact on reducing workplace violence, use of coercive measures and increasing nurses' job satisfaction in adult psychiatric inpatient care.

Read the detailed description

The study includes three phases: 1) exploring attitudes of nurses and nurse managers towards validated tools, violence risk assessment and management, 2) a pre-implementation including a co-design process of the eDASA+APP to ensure optimal integration and adaptation to local context and integration into the local EPIC based EHR system together with relevant stakeholders (health care staff and expert-by-experience), and 3) a quasi-experimental implementation study to evaluate the impact of the intervention (eDASA+APP FI).

02

Conditions studied

  • Violence

Keywords

  • violence risk assessment
  • DASA
  • Dynamic Appraisal of Situational Aggression
  • mental health nursing
  • EPIC
  • electronic health records
  • violence risk management
  • inpatient psychiatric care
  • coercive measures
  • clinical decision support system
  • CDSS
  • co-design
  • nurse-patient collaboration
03

In context

Lead sponsor

University of Turku is the lead sponsor of 122 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adult psychiatric wards

Exclusion criteria

Exclusion Criteria:

  • psychiatric wards specialized only for the care of people with intellectual disabilities, wards providing care for both adults and underaged patients (eating disorder units)
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    eDASA+APP FI

    Nurses in the study wards are using a CDSS 'eDASA+APP FI' in their daily clinical work to aid their short-term violence risk assessment and management, together with a patient if possible, to identify patients at elevated risk for violence in the coming 24 hours and to decrease (or maintain low) the risk with evidence-based, non-invasive nursing interventions.

    Behavioral: eDASA+APP FI

Interventions

  • BehavioraleDASA+APP FI

    A CDSS for nurses to assist in their daily short-term violence risk assessment and management, is integrated into an EPIC-based EHR system.

06

What researchers measure

Primary outcomes

  1. Workplace violence

    Violence experienced by healthcare staff in the wards, routinely collected data

    Time frame: Pre-post (3 months)

Secondary outcomes

  1. Coercive measures

    Routinely monitored and collected by the wards according to the Finnish Mental Health Act

    Time frame: Pre-post (3 months)

  2. Job satisfaction

    Nurses yearly job satisfaction survey will be used (Nurse Engagement Survey (NESplus))

    Time frame: Pre-post (3 months)

07

Study locations

1 site
  • HUS University Hospital
    Helsinki, Finland
08

References and documents

Publications

  • Griffith JJ, Meyer D, Maguire T, Ogloff JRP, Daffern M. A Clinical Decision Support System to Prevent Aggression and Reduce Restrictive Practices in a Forensic Mental Health Service. Psychiatr Serv. 2021 Aug 1;72(8):885-890. doi: 10.1176/appi.ps.202000315. Epub 2021 May 17. PubMed 33993715 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06342531
Lead sponsor
University of Turku
Collaborators
Helsinki University Central Hospital
Responsible party
Tella Lantta (Adjunct Professor, University of Turku) — Principal investigator
First posted
Apr 2, 2024
Start date
Jun 1, 2024
Primary completion
Dec 1, 2024
Completion
Dec 2026 (estimated)
Last update
Apr 6, 2025

Study contacts

Tella Lantta, PhD
principal investigator · Department of Nursing Science, University of Turku, Finland

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion